| dc.contributor.author | Muir, K. R. | |
| dc.contributor.author | Lima, M. J. | |
| dc.contributor.author | Docherty, H. M. | |
| dc.contributor.author | Docherty, K. | |
| dc.date.accessioned | 2016-02-02T09:40:01Z | |
| dc.date.available | 2016-02-02T09:40:01Z | |
| dc.date.issued | 2014-04 | |
| dc.identifier | 29993437 | |
| dc.identifier | 06c2b575-fc76-4e99-97fc-bded2aed7193 | |
| dc.identifier | 84897061262 | |
| dc.identifier.citation | Muir , K R , Lima , M J , Docherty , H M & Docherty , K 2014 , ' Cell Therapy for Type 1 Diabetes ' , QJM , vol. 107 , no. 4 , pp. 253-259 . https://doi.org/10.1093/qjmed/hcu025 | en |
| dc.identifier.issn | 1460-2725 | |
| dc.identifier.uri | http://hdl.handle.net/2164/5471 | |
| dc.description | Acknowledgements The work described in this review was supported by a grant from the MRC. K.R.M. is supported by a fellowship from the Scottish Translational Medicines and Therapeutics Initiative through the Wellcome Trust. | en |
| dc.format.extent | 7 | |
| dc.format.extent | 213512 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | QJM | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | R Medicine | en |
| dc.subject.lcc | R | en |
| dc.title | Cell Therapy for Type 1 Diabetes | en |
| dc.type | Journal article | en |
| dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
| dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
| dc.description.status | Peer reviewed | en |
| dc.identifier.doi | 10.1093/qjmed/hcu025 | |
